{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = 1-(2-Bromo-1,2-diphenylethenyl)-4-ethylbenzene
| image = Broparestrol.svg
| width =

<!--Clinical data-->
| tradename = Acnestrol, Longestrol
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = X (Contraindicated)
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = Rx-only
| routes_of_administration = [[Oral administration|Oral]]

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 479-68-5
| CAS_number2 = 22393-63-1
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 3032769
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 2297663
| UNII = 4F4UXV47YI
| UNII2 = D6CYJ2NI2L
| index2_label = Z-isomer
<!--Chemical data-->
| C=22 | H=19 | Br=1
| molecular_weight = 363.29026 g/mol
| smiles            = CCc1ccc(cc1)/C(=C(\c2ccccc2)/Br)/c3ccccc3
| StdInChI_Ref = 
| StdInChIKey_Ref = 
| StdInChI          = 1S/C22H19Br/c1-2-17-13-15-19(16-14-17)21(18-9-5-3-6-10-18)22(23)20-11-7-4-8-12-20/h3-16H,2H2,1H3/b22-21+
| StdInChIKey       = OQCYTSHIQNPJIC-QURGRASLSA-N
| synonyms = LN-107; α-Bromo-α,β-diphenyl-β-p-ethylphenylethylene; BDPE
}}

'''Broparestrol''' ([[International Nonproprietary Name|INN]]) (brand names '''Acnestrol''', '''Longestrol'''; former developmental code name '''LN-107'''), also known as '''α-bromo-α,β-diphenyl-β-p-ethylphenylethylene''' ('''BDPE'''), is a [[Organic compound#Synthetic compounds|synthetic]], [[nonsteroidal]] [[selective estrogen receptor modulator]] (SERM) of the [[triphenylethylene]] group<ref name="JamesPasqualini2013">{{cite book|author1=V. H. T. James|author2=J. R. Pasqualini|title=Proceedings of the Fourth International Congress on Hormonal Steroids: Mexico City, September 1974|url=https://books.google.com/books?id=Iq0aAwAAQBAJ&pg=PA223|date=22 October 2013|publisher=Elsevier Science|isbn=978-1-4831-4566-2|pages=223–}}</ref> that is or was used in [[Europe]] as a [[dermatology|dermatological agent]] and for the treatment of [[breast cancer]].<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA183|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=183–}}</ref><ref>{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA139|date=January 2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=139–}}</ref><ref name="Muller1998">{{cite book|author=Muller|title=European Drug Index: European Drug Registrations, Fourth Edition|url=https://books.google.com/books?id=2HBPHmclMWIC&pg=PA23|date=19 June 1998|publisher=CRC Press|isbn=978-3-7692-2114-5|pages=23–}}</ref><ref name="MortonHall2012">{{cite book|author1=I.K. Morton|author2=Judith M. Hall|title=Concise Dictionary of Pharmacological Agents: Properties and Synonyms|url=https://books.google.com/books?id=tsjrCAAAQBAJ&pg=PA56|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-94-011-4439-1|pages=56–}}</ref> The drug is described as slightly [[estrogen]]ic<ref name="VilleeHagerman1957">{{cite journal|last1=Villee|first1=Claude A.|last2=Hagerman|first2=Dwain D.|title=COMPOUNDS WITH ANTIESTROGENIC ACTIVITY IN VITRO1|journal=Endocrinology|volume=60|issue=4|year=1957|pages=552–558|issn=0013-7227|doi=10.1210/endo-60-4-552}}</ref> and potently [[antiestrogen]]ic,<ref name="Al-Hassan1987">{{cite journal|last1=Al-Hassan|first1=Mohammed I.|title=Synthesis of broparestrol using palladium-catalyzed cross-coupling|journal=Journal of Organometallic Chemistry|volume=321|issue=1|year=1987|pages=119–121|issn=0022-328X|doi=10.1016/0022-328X(87)80330-3}}</ref><ref name="Publishers1994">{{cite book|author=Bentham Science Publishers|title=Current Medicinal Chemistry|url=https://books.google.com/books?id=JMd5FWm6GTkC&pg=PA95|date=May 1994|publisher=Bentham Science Publishers|pages=95–}}</ref> and inhibits [[mammary gland development]] and suppresses [[prolactin]] levels in animals.<ref name="pmid6245799">{{cite journal | vauthors = Drosdowsky M, Edery M, Guggiari M, Montes-Rendon A, Rudali G, Vives C | title = Inhibition of prolactin-induced mammary cancer in C3Hf (XVII) mice with the trans isomer of bromotriphenylethylene | journal = Cancer Res. | volume = 40 | issue = 5 | pages = 1674–9 | year = 1980 | pmid = 6245799 | doi = | url = }}</ref> It is structurally related to [[clomifene]] and [[diethylstilbestrol]].<ref name="MortonHall2012" /><ref name="pmid6245799" />

Broparestrol is a mixture of ''E-'' and ''Z-'' [[isomer]]s (LN-1643 and LN-2299, respectively), both of which are active and are similarly antiestrogenic but, unlike broparestrol, were never marketed.<ref name="Elks2014" />

==See also==
* [[Chlorotrianisene]]
* [[Estrobin]]
* [[Tamoxifen]]
* [[Stilbestrol]]
* [[Ethamoxytriphetol]]

==References==
{{reflist|30em}}

{{Estrogens}}
{{Estrogenics}}

[[Category:Organobromides]]
[[Category:Selective estrogen receptor modulators]]
[[Category:Synthetic estrogens]]
[[Category:Triphenylethylenes]]


{{genito-urinary-drug-stub}}